Literature DB >> 28655166

Communication in Multiple Sclerosis: Pragmatic Deficit and its Relation with Cognition and Social Cognition.

Antonio Carotenuto1, Giorgio Arcara2, Giuseppe Orefice1, Ilaria Cerillo1, Valentina Giannino1, Mario Rasulo1, Rosa Iodice1, Valentina Bambini3.   

Abstract

OBJECTIVE: Cognitive functions have been largely investigated in multiple sclerosis. Less attention has been paid to social communication abilities, despite their presumptive affect on quality of life. We run the first comprehensive assessment of pragmatic skills in multiple sclerosis, evaluating also the relationship between pragmatics and other cognitive domains.
METHODS: Forty-two multiple sclerosis patients and 42 controls were tested for pragmatic abilities, neuro-cognition, social cognition, depression, and fatigue.
RESULTS: Patients performed poorly in most pragmatic tasks compared to controls. Globally, 55% of patients performed below the 5th percentile in the total pragmatic score. Notably, pragmatic skills did not differ between cognitively impaired and unimpaired patients. However, an association was found between pragmatics and verbal fluency, as measured in the Word List Generation. Finally, we observed an association of pragmatic abilities with social cognition, and a trend with psychosocial functioning.
CONCLUSION: Overall, the study shows a diffuse pragmatic impairment in multiple sclerosis, not associated with the patient's global neuropsychological profile. By contrast, our findings suggest a close relation between pragmatics and specific cognitive aspects such as executive functions, and between pragmatics and social cognition. This study underlines the need of looking beyond classical cognitive performance, to consider underestimated communicative disturbances of high clinical relevance.
© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2018        PMID: 28655166     DOI: 10.1093/arclin/acx061

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  7 in total

1.  What is the contribution of executive functions to communicative-pragmatic skills? Insights from aging and different types of pragmatic inference.

Authors:  Valentina Bambini; Lotte Van Looy; Kevin Demiddele; Walter Schaeken
Journal:  Cogn Process       Date:  2021-03-30

2.  Update on Recent Developments in Communication and Swallowing in Multiple Sclerosis.

Authors:  Francesca De Biagi; Leena Maria Heikkola; Sara Nordio; Leonie Ruhaak
Journal:  Int J MS Care       Date:  2020-12-28

3.  Effect of Multiple Sclerosis on Daily Activities, Emotional Well-being, and Relationships: The Global vsMS Survey.

Authors:  Ann D Bass; Bart Van Wijmeersch; Lori Mayer; Mathias Mäurer; Aaron Boster; Matt Mandel; Colin Mitchell; Kersten Sharrock; Barry Singer
Journal:  Int J MS Care       Date:  2019-08-28

4.  Variables Associated with Self-reported Language Impairment in Multiple Sclerosis: A Regression Analysis.

Authors:  Sarah El-Wahsh; Rob Heard; Hans Bogaardt; Fiona Kumfor; Kirrie J Ballard
Journal:  Int J MS Care       Date:  2021-04-14

5.  Cognitive Processes Underlying Verbal Fluency in Multiple Sclerosis.

Authors:  Alfonso Delgado-Álvarez; Jordi A Matias-Guiu; Cristina Delgado-Alonso; Laura Hernández-Lorenzo; Ana Cortés-Martínez; Lucía Vidorreta; Paloma Montero-Escribano; Vanesa Pytel; Jorge Matias-Guiu
Journal:  Front Neurol       Date:  2021-01-21       Impact factor: 4.003

6.  The Understanding of Scalar Implicatures in Children With Autism Spectrum Disorder: Dichotomized Responses to Violations of Informativeness.

Authors:  Walter Schaeken; Marie Van Haeren; Valentina Bambini
Journal:  Front Psychol       Date:  2018-07-23

7.  Managing communication changes in persons with multiple sclerosis: Findings from qualitative focus groups.

Authors:  Sarah El-Wahsh; Susan Balandin; Hans Bogaardt; Fiona Kumfor; Kirrie J Ballard
Journal:  Int J Lang Commun Disord       Date:  2022-03-26       Impact factor: 2.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.